The question is would taking a telomerase activator help, hinder, or have no difference in new cancer formation?
Google alerts for “telomeres” posted this interesting study validating my idea that replicative senescence is at the heart of liver disease. They engineered mice to have poor telomere repair and then watched as the large cell liver histology typical in hepatitis and cirrhosis developed.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
